Spots Global Cancer Trial Database for 18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: 18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor

Official Title: 18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor

Study ID: NCT06126705

Conditions

Tumor, Solid

Interventions

Radiation: 18F-AlF-FAPi-04

Radiation: 18F-FDG

Study Description

Brief Summary: To evaluate the potential usefulness of 18F-AlF-FAPi-04 PET/CT for the diagnosis of primary and metastatic lesions in solid cancer.

Detailed Description: This is a prospective, single-center, two arms, open label, non-randomized study to evaluate the ability of 18F-AlF-FAPi-04 to detect FAP expressing cells in patients with solid tumor, evaluate its biological distribution characteristics, impact on clinical treatment plans, and evaluate imaging differences between different probes. Taking histopathology and imaging follow-up as gold standard, the sensitivity, specificity, and accuracy of 18F-AlF-FAPi-04 PET/CT will be calculated.